Search Count: 151
 |
Sars-Cov-2 Nsp14 With 1-(4-Methylphenyl)-2-(2-Methylsulfanyl-4,5-Dihydroimidazol-1-Yl)Ethanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9H, DMS, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9H, DMS, ZN
 |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1AYN, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1AYN, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With Ethyl 2-(1H-Indol-3-Yl)Acetate
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9J, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9J, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dimethylpyrazol-3-Amine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9K, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9K, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With N-Methyl-1-(2-Methyl-5-Phenylpyrazol-3-Yl)Methanamine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: X6W, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: X6W, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 1-Benzofuran-3-Carboxylic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA8, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA8, DMS, EPE, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2-(1H-Indol-3-Yl)Ethanol
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: ZCW, DMS, PO4, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: ZCW, DMS, PO4, ZN
 |
Sars-Cov-2 Nsp14 With Benzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: FB2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: FB2, EPE, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 5-Chlorothiophene-2-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: GOL, 8K2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: GOL, 8K2, EPE, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 3,4-Dichlorobenzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBC, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBC, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dichloro-4-Methylthiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBA, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBA, DMS, EPE, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA9, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA9, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With Thiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBB, DMS, EPE, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBB, DMS, EPE, ZN
 |
Sars-Cov-2 Nsp14 With 6-Methyl-2-[(4-Methylphenyl)Methyl]Pyridazin-3-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-04-15 Classification: VIRAL PROTEIN Ligands: A1I9I, DMS, PO4, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-15
Ligands: A1I9I, DMS, PO4, ZN
 |
Sars-Cov-2 Nsp14 With 5-(Thiophen-2-Ylmethylamino)-3H-1,3,4-Thiadiazole-2-Thione
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2026-04-15 Classification: VIRAL PROTEIN Ligands: DMS, A1I9Y, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-15
Ligands: DMS, A1I9Y, ZN, PO4
 |
Crystal Structure Of Human Erk1 In Complex With The Kim1 Motif Of The T. Gondii Protein Gra24
Organism: Homo sapiens, Toxoplasma gondii
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2026-02-25 Classification: TRANSFERASE Ligands: SO4 |
Organism: Homo sapiens, Toxoplasma gondii
Method: X-RAY DIFFRACTION
Release Date: 2026-02-25
Ligands: SO4
 |
Structure Of The Map2K Mek1 Without Bound Nucleotide In Complex With Its Substrate Mapk Erk2
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY Resolution:3.60 Å Release Date: 2026-02-25 Classification: SIGNALING PROTEIN |
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY
Release Date: 2026-02-25
 |
Structure Of The Map2K Mek1 In An Inactive Conformation In Complex With Its Substrate Mapk Erk2
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY Release Date: 2026-02-11 Classification: SIGNALING PROTEIN Ligands: ADP, MG |
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY
Release Date: 2026-02-11
Ligands: ADP, MG
 |
Structure Of The Map2K Mek1 In An Active Conformation In Complex With Its Substrate Mapk Erk2
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY Release Date: 2026-02-11 Classification: SIGNALING PROTEIN Ligands: ADP |
Organism: Homo sapiens, Toxoplasma gondii me49
Method: ELECTRON MICROSCOPY
Release Date: 2026-02-11
Ligands: ADP
 |
Human Phosphoglycerate Kinase In With Mixture Of Products And Substrates Produced By Cross-Soaking A Tsa Crystal
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2025-10-29 Classification: TRANSFERASE Ligands: ATP, X15, NA, CL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-10-29
Ligands: ATP, X15, NA, CL